SANTA FE SPRINGS, Calif.–Applied BioCode, Inc. today announced that it has signed a License and Supply Agreement (Agreement) with Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products. Hologic is headquartered in Bedford, MA. Under the Agreement Hologic may purchase Barcoded Magnetic Beads with digital multiplex […]
Guildford, UK, and Burlington, Mass. – Governor Deval Patrick and the Massachusetts Life Sciences Center today joined officials from IDBS to open the company’s Healthcare Center of Excellence and to celebrate the expansion of the IDBS business in Massachusetts. The events stemmed from a meeting between UK-based IDBS, Governor Patrick, the Center and other Massachusetts […]
Thermo Fisher Scientific Inc., the world leader in serving science, today announced a collaboration with De Novo Software (Los Angeles, CA, USA) to provide users of the popular FCS Express software access to data generated by Thermo Scientific high-content platforms. With the increasing adoption of high-content/image cytometry from basic cell biology through drug discovery, toxicology […]
CARLSBAD, Calif. and SAN FRANCISCO — Life Technologies Corporation (NASDAQ: LIFE) today announced several new products and protocols to improve workflows for Ion Torrent DNA sequencing applications, demonstrating the unparalleled speed, scalability and simplicity that Ion Torrent delivered in 2011. “In 2011 we scaled semiconductor sequencing 100x and simplified the workflow with Ion OneTouch ™,” […]
OCKVILLE, Md. — BioReliance, a leading provider of global biopharmaceutical testing services, announced today that it has agreed to be acquired by Sigma-Aldrich Corporation (NASDAQ: SIAL). Avista Capital Partners, the majority owner of BioReliance Holdings, Inc., agreed to sell the company for $350 million in cash. The acquisition is subject to customary closing conditions, including […]
Granada and Madrid, Spain and Philadelphia, PA, U.S. – Integromics(R), a market leader in IT solutions provision for life sciences in the field of genomics and proteomics, today announces the release of SeqSolve 2.1(TM), its analytical software package which makes the analysis of Next Generation Sequencing (NGS) data simpler. SeqSolve 2.1 provides scientists with a […]
CAMBRIDGE, MA – Knome, Inc., the human genome interpretation company, today announced that it has appointed Martin Tolar, MD, PhD, as the company’s Chief Executive Officer. In addition, Knome has expanded the management team as the company pursues new growth opportunities to interpret and apply genomic information across the healthcare community—including academic researchers, drug companies, […]
CAMBRIDGE, MA – Knome, Inc., the human genome interpretation company, today announced that it has been awarded a contract by the Johns Hopkins University School of Medicine. Under the agreement, Knome will supply its informatics services and software tools to Johns Hopkins’ landmark study to uncover genetic variants that contribute to asthma in African American […]
SAN DIEGO — Gen-Probe’s (NASDAQ: GPRO) multiple new product launches are off to a good start and should help drive accelerating, double-digit revenue growth in 2012, according to Carl Hull, Gen-Probe’s chairman and CEO, who will discuss the Company’s 2011 accomplishments and future strategies with investors at JP Morgan’s 30th annual healthcare conference in San […]
CAMBRIDGE, Mass.–Knome, Inc., the human genome interpretation company, today announced that it has expanded its scientific advisory board to include two respected experts in genomics, Dr. David Goldstein of Duke University and Dr. Yaniv Erlich of the Whitehead Institute for Biomedical Research. “We are very pleased to appoint two highly talented genomics experts to our […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
